english Icono del idioma   español Icono del idioma  

Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/20.500.12008/55139 Cómo citar
Título: Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women
Autor: Almeida, Liz Maria de
Cortés, Sandra
Vilensky, Marta
Valenzuela, Olivia
Cortes-Sanabria, Laura
de Souza, Mirian
Barbeito, Rafael Alonso
Abdelhay, Eliana
Artagaveytia, Nora
Daneri-Navarro, Adrián
Llera, Andrea Sabina
Müller, Bettina
Podhajcer, Osvaldo L.
Velázquez, Carlos
Alcoba, Elsa
Alonso, Isabel
Bravo, Alicia Inés
Camejo, Natalia
Carraro, Dirce Maria
Castro, Mónica
Cataldi, Sandra
Cayota, Alfonso
Cerda, Mauricio
Colombo, Alicia
Crocamo, Susanne
Del Toro-Arreola, Alicia
Delgadillo-Cristerna, Raul
Delgado, Lucía
Dreyer Breitenbach, Marisa
Fernández, Elmer
Fernández, Jorge
Fernández, Wanda
Franco-Topete, Ramón A.
Gaete, Fancy
Gómez, Jorge
Gonzalez-Ramirez, Leivy P.
Guerrero, Marisol
Gutierrez-Rubio, Susan A.
Jalfin, Beatriz
Lopez-Vazquez, Alejandra
Loria, Dora
Míguez, Silvia
Moran-Mendoza, Andrés de J.
Morgan-Villela, Gilberto
Mussetti, Carina
Nagai, María Aparecida
Oceguera-Villanueva, Antonio
Reis, Rui Manuel
Retamales, Javier
Rodríguez, Robinson
Rosales, Cristina
Salas-Gonzalez, Efrain
Segovia, Laura
Sendoya, Juan M.
Silva-Garcia, Aida A.
Viña, Stella
Zagame, Livia
Jones, Beth
Szklo, Moysés
Tipo: Artículo
Palabras clave: Latin America, Breast cancer, Global excellence, Molecular subtypes, Oncology, Prognosis, Risk factors
Descriptores: NEOPLASIAS DE LA MAMA, DISPARIDADES SOCIOECONÓMICAS EN SALUD, FACTORES SOCIOECONÓMICOS, MUJERES, ONCOLOGÍA, FACTORES DE RIESGO, PRONÓSTICO, ANÁLISIS DE SUPERVIVENCIA, SOBREVIDA
Fecha de publicación: 2022
Resumen: Molecular profile of breast cancer in Latin-American women was studied in five countries: Argentina, Brazil, Chile, Mexico, and Uruguay. Data about socioeconomic characteristics, risk factors, prognostic factors, and molecular subtypes were described, and the 60-month overall cumulative survival probabilities (OS) were estimated. From 2011 to 2013, 1,300 eligible Latin-American women 18 years or older, with a diagnosis of breast cancer in clinical stage II or III, and performance status ≦̸1 were invited to participate in a prospective cohort study. Face-to-face interviews were conducted, and clinical and outcome data, including death, were extracted from medical records. Unadjusted associations were evaluated by Chi-squared and Fisher's exact tests and the OS by Kaplan-Meier method. Log-rank test was used to determine differences between cumulative probability curves. Multivariable adjustment was carried out by entering potential confounders in the Cox regression model. The OS at 60 months was 83.9%. Multivariable-adjusted death hazard differences were found for women living in Argentina (2.27), Chile (1.95), and Uruguay (2.42) compared with Mexican women, for older (≥60 years) (1.84) compared with younger (≤40 years) women, for basal-like subtype (5.8), luminal B (2.43), and HER2-enriched (2.52) compared with luminal A subtype, and for tumor clinical stages IIB (1.91), IIIA (3.54), and IIIB (3.94) compared with stage IIA women. OS was associated with country of residence, PAM50 intrinsic subtype, age, and tumor stage at diagnosis. While the latter is known to be influenced by access to care, including cancer screening, timely diagnosis and treatment, including access to more effective treatment protocols, it may also influence epigenetic changes that, potentially, impact molecular subtypes. Data derived from heretofore understudied populations with unique geographic ancestry and sociocultural experiences are critical to furthering our understanding of this complexity.
Descripción: Liz Maria de Almeida 1, Sandra Cortés 2, Marta Vilensky 3, Olivia Valenzuela 4, Laura Cortes-Sanabria 5, Mirian de Souza 1, Rafael Alonso Barbeito 6, Eliana Abdelhay 1, Nora Artagaveytia 7, Adrian Daneri-Navarro 8, Andrea S Llera 9, Bettina Müller 10, Osvaldo L Podhajcer 9, Carlos Velazquez 4, Elsa Alcoba 11, Isabel Alonso 12, Alicia I Bravo 13, Natalia Camejo 7, Dirce Maria Carraro 14, Mónica Castro 3, Sandra Cataldi 15, Alfonso Cayota 16, Mauricio Cerda 17, Alicia Colombo 17, Susanne Crocamo 1, Alicia Del Toro-Arreola 8, Raul Delgadillo-Cristerna 5, Lucia Delgado 7, Marisa Dreyer Breitenbach 18, Elmer Fernández 19, Jorge Fernández 20, Wanda Fernández 21, Ramon A Franco-Topete 22, Fancy Gaete 23, Jorge Gómez 24, Leivy P Gonzalez-Ramirez 8, Marisol Guerrero 25, Susan A Gutierrez-Rubio 8, Beatriz Jalfin 13, Alejandra Lopez-Vazquez 4, Dora Loria 3, Silvia Míguez 11, Andres de J Moran-Mendoza 26, Gilberto Morgan-Villela 5, Carina Mussetti 27, Maria Aparecida Nagai 28, Antonio Oceguera-Villanueva 29, Rui M Reis 30, Javier Retamales 31, Robinson Rodriguez 32, Cristina Rosales 11, Efrain Salas-Gonzalez 25, Laura Segovia 33, Juan M Sendoya 9, Aida A Silva-Garcia 22, Stella Viña 3, Livia Zagame 29, Beth Jones 34, Moysés Szklo 35; United States-Latin American Cancer Research Network (US-LACRN)
Affiliations 1Instituto Nacional de Câncer, Rio de Janeiro, Brazil. 2Pontificia Universidad Católica de Chile, Santiago, Chile. 3Instituto de Oncología Angel Roffo, Buenos Aires, Argentina. 4Universidad de Sonora, Hermosillo, Mexico. 5Hospital de Especialidades, CMNO-IMSS, Guadalajara, Mexico. 6Facultad de Medicina, Montevideo, Uruguay. 7Hospital de Clínicas Manuel Quintela, Universidad de la República, Montevideo, Uruguay. 8Universidad de Guadalajara, Guadalajara, Mexico. 9Fundación Instituto Leloir, CONICET, Buenos Aires, Argentina. 10Instituto Nacional del Cáncer, Santiago, Chile. 11Hospital Municipal de Oncología María Curie, Buenos Aires, Argentina. 12Centro Hospitalario Pereira Rossell, Montevideo, Uruguay. 13Hospital Regional de Agudos Eva Perón, Buenos Aires, Argentina. 14AC Camargo Cancer Center, São Paulo, Brazil. 15Instituto Nacional de Cáncer, Montevideo, Uruguay. 16Institut Pasteur de Montevideo, Montevideo, Uruguay. 17Universidad de Chile, Santiago, Chile. 18Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil. 19Universidad Católica de Córdoba, Centro de Investigaciones en Bioquímica Clínica e Inmunologia-CONICET, Córdoba, Argentina. 20Instituto de Salud Pública, Santiago, Chile. 21Hospital San Borja Arriarán, Santiago, Chile. 22OPD Hospital Civil de Guadalajara, Universidad de Guadalajara, Guadalajara, Mexico. 23Hospital Luis Tisne, Santiago, Chile. 24Texas A&M University, Houston, TX, United States. 25Hospital San José, Santiago, Chile. 26Hospital de Gineco-Obstetricia CMNO-IMSS, Guadalajara, Mexico. 27Registro Nacional de Cancer, Montevideo, Uruguay. 28Instituto de Câncer de São Paulo, São Paulo, Brazil. 29Instituto Jalisciense de Cancerologia, Guadalajara, Mexico. 30Hospital de Câncer de Barretos, Barretos, Brazil. 31Grupo Oncológico Cooperativo Chileno de Investigación, Santiago, Chile. 32Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay. 33Hospital Barros Luco Trudeau, Santiago, Chile. 34Yale School of Public Health, Yale University, New Heaven, CT, United States. 35Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States.
Editorial: Frontiers Media
EN: Frontiers in Oncology. 2022;12
Citación: Almeida L, Cortés S, Vilensky M y otros. Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women. Frontiers in Oncology [en línea]. 2022;12. 15 p.
Cobertura geográfica: AMÉRICA LATINA
Cobertura temporal: 2012 - 2013
Licencia: Licencia Creative Commons Atribución (CC - By 4.0)
Aparece en las colecciones: Publicaciones Académicas y Científicas - Facultad de Medicina

Ficheros en este ítem:
Fichero Descripción Tamaño Formato   
Socioeconomic Clinical and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women.pdfSocioeconomic Clinical and Molecular Features of Breast Cancer Influence28,08 MBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons